Potential mechanisms by which alcohol modulates Alzheimer’s disease (AD) pathology
Schematic representation of the potential mechanisms by which alcohol modulates Alzheimer’s disease (AD) pathology. Alcohol consumption can activate Toll-like receptors, which trigger the innate immune response, aggravate microglial activation, and cause neuroinflammation and neuronal cell death (1). Chronic alcohol intake can also activate the mTOR/Akt pathway, which phosphorylates GSK-3 and causes tau hyperphosphorylation, leading to neurodegeneration (2). Alcohol is also known to upregulate the CDK5 and GSK-3β kinase activities, leading to tau hyperphosphorylation (3). Alcohol is additionally known to alter the PKA/CREB signaling pathway and increase BACE-1 activity, leading to the upregulation and deposition of Aβ (4). Similarly, chronic alcohol intake can increase APP levels and BACE-1 activity, leading to increased Aβ production (5). Additionally, alcohol intake causes thiamine deficiency, which activates BACE-1 and microglial cells and triggers proinflammatory cytokine release, leading to Aβ accumulation (6). Chronic alcohol intake also dysregulates the cholinergic and endocannabinoid system, leading to cognitive decline (7). Chronic alcohol intake is additionally known to disrupt insulin signaling and impair the cholinergic system, increasing Aβ deposition, neuronal loss, and cognitive deficits (8). Alcohol intake is known to cause BBB (9) and microglial (10) dysfunction, which are significant drivers of AD pathology and cognitive deficits. Apart from these cerebral effects of alcohol, other potential mechanisms by which alcohol can modulate AD pathology include an increase in Aβ accumulation with aldehyde dehydrogenase deficiency and alterations in hepatic Aβ processing associated with liver injury. The latter may act as a source of brain Aβ. The figure was created using BioRender.com. Aβ, Amyloid beta; AD, Alzheimer’s disease; APP, amyloid precursor protein; BACE-1, β-Site APP-cleaving enzyme 1; BBB, blood–brain barrier; CDK5, cyclin-dependent kinase-5; CREB, cyclic adenosine monophosphate (cAMP) response element-binding protein; GSK3, glycogen synthase kinases; mTOR, mammalian target of rapamycin; PKA, protein kinase A